Evidence That the Blood Biomarker SNTF Predicts Brain Imaging Changes and Persistent Cognitive Dysfunction in Mild TBI Patients
Open Access
- 1 January 2013
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 71158
Abstract
Although mild traumatic brain injury (mTBI), or concussion, is not typically associated with abnormalities on computed tomography (CT), it nevertheless causes persistent cognitive dysfunction for many patients. Consequently, new prognostic methods for mTBI are needed to identify at risk cases, especially at an early and potentially treatable stage. Here, we quantified plasma levels of the neurodegeneration biomarker calpain-cleaved αII-spectrin N-terminal fragment (SNTF) from 38 participants with CT-negative mTBI, orthopedic injury (OI), and normal uninjured controls (UCs) (age range 12–30 years), and compared them with findings from diffusion tensor imaging (DTI) and long-term cognitive assessment. SNTF levels were at least twice the lower limit of detection in 7 of 17 mTBI cases and in 3 of 13 OI cases, but in none of the UCs. An elevation in plasma SNTF corresponded with significant differences in fractional anisotropy and the apparent diffusion coefficient in the corpus callosum and uncinate fasciculus measured by DTI. Furthermore, increased plasma SNTF on the day of injury correlated significantly with cognitive impairment that persisted for at least 3 months, both across all study participants and also among the mTBI cases by themselves. The elevation in plasma SNTF in the subset of OI cases, accompanied by corresponding white matter and cognitive abnormalities, raises the possibility of identifying undiagnosed cases of mTBI. These data suggest that the blood level of SNTF on the day of a CT-negative mTBI may identify a subset of patients at risk of white matter damage and persistent disability. SNTF could have prognostic and diagnostic utilities in the assessment and treatment of mTBI.Keywords
This publication has 59 references indexed in Scilit:
- Axonal pathology in traumatic brain injuryExperimental Neurology, 2013
- Application of Blood-Based Biomarkers in Human Mild Traumatic Brain InjuryFrontiers in Neurology, 2013
- Diffusion tensor imaging studies of mild traumatic brain injury: a meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Calpain as a Therapeutic Target in Traumatic Brain InjuryNeurotherapeutics, 2010
- Factor Analysis of the Rivermead Post-Concussion Symptoms Questionnaire in Mild-to-Moderate Traumatic Brain Injury PatientsThe Journal of Neuropsychiatry and Clinical Neurosciences, 2009
- Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in ratsJournal of Neurochemistry, 2001
- Prolonged Calpain-mediated Spectrin Breakdown Occurs Regionally Following Experimental Brain Injury in the RatJournal of Neuropathology & Experimental Neurology, 1996
- The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliabilityJournal of Neurology, 1995
- Fodrin: axonally transported polypeptides associated with the internal periphery of many cells.Journal of Cell Biology, 1981
- Response selection in keeping track of several things at onceActa Psychologica, 1967